Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway

Journal of Endocrinology

Volumn 213, Issue 1, 2012, Pages 77-87

  Campelo, Adrián E ^a,b   Cutini, Pablo H ^a,b   Massheimer, Virginia L ^a,b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM; CHELERYTHRINE; DNA; FLUTAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; N NITRO LEVO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; TESTOSTERONE; UNCLASSIFIED DRUG; VERAPAMIL; ANDROGEN; BENZOPHENANTHRIDINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; FLAVONOID;

ARTICLE; CALCIUM TRANSPORT; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; PHYSIOLOGY;

ANDROGENS; ANIMALS; BENZOPHENANTHRIDINES; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; ENDOTHELIAL CELLS; FLAVONOIDS; NITRIC OXIDE; PLATELET AGGREGATION; RATS; TESTOSTERONE; VERAPAMIL;

EID: 84860792205     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0441     Document Type: Article

References (48)

1. Bachetti T & Morbidelli L 2000 Endothelial cells in culture: a model for studying vascular functions. Pharmacological Research 42 9-19.
2. Cooke JP & Dzau VJ 1997 Nitric oxide synthase: role in genesis of vascular disease. Annual Review of Medicine 48 489-509.
3. Cutini P, Sellés J & Massheimer V 2009 Cross-talk between rapid and long term effects of progesterone on vascular tissue. Journal of Steroid Biochemistry and Molecular Biology 115 36-43.
4. Duckles SP & Miller VM 2010 Hormonal modulation of endothelial NO production. Pflügers Archiv: European Journal of Physiology 459 841-851.
5. Falkenstein E, Tillmann HC, Christ M, Feuring M & Wehling M 2000 Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacological Reviews 52 513-556.
6. Farhat MY, Lavigne MC & Ramwell PW 1996 The vascular protective effects of estrogen. FASEB Journal 10 615-624.
7. Förstermann U 2010 Nitric oxide and oxidative stress in vascular disease. Pflügers Archiv: European Journal of Physiology 459 923-939.
8. Goglia L, Tosi V, Sanchez AM, Flamini MI, Fu XD, Zullino S, Genazzani AR & Simoncini T 2010 Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotesterone in vitro and in vivo. Molecular Human Reproduction 16 761-769.
9. Gryglewski RJ, Palmer RM & Moncada S 1986 Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320 454-456.
10. Han G, Ma H, Chintala R, Miyake K, Fulton DJ, Barman SA & White RE 2007 Non genomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signalling. American Journal of Physiology. Heart and Circulatory Physiology 293 H314-H321.
11. Harrison DG, Widder J, Grumbach I, Chem W, Weber M & Searles C 2006 Endothelial mechanotransduction, nitric oxide and vascular inflammation. Journal of Internal Medicine 259 351-363.
12. Hsia J, LangerRD, Manson JE, Kuller L, JohnsonKC, Hendrix SL, PettingerM, Heckbert SL, Greep N, Crawford S et al. 2006 Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Archives of Internal Medicine 166 357-365.
13. Ignarro LJ 1989 Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circulation Research 65 1-21.
14. Ignarro LJ, Cirino G, Casini A & Napoli C 1999 Nitric oxide as a signaling molecule in the vascular system: an overview. Journal of Cardiovascular Pharmacology 34 879-886.
15. Jesmin S, Togashi H, Sakuma I, Mowa CN, Ueno K, Yamaguchi T, Yoshioka M & Kitabatake A 2004 Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder. Endocrinology 145 4330-4343.
16. Jones RD, English KM, Pugh PJ, Morice AH, Jones TH & Channer KS 2002 Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. Journal of Cardiovascular Pharmacology 39 814-823.
17. Jones RD, English KM, Jones TH & Channer KS 2004 Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clinical Science 107 149-158.
18. Kanno K, Hirata Y, Imai T, Iwashina M & Marumo F 1994 Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. American Journal of Physiology 36 H2318-H2324.
19. Kikuta K, Sawamura T, Miwa S, Hashimoto N & Masaki T 1998 High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine. Circulation Research 83 1088-1096.
20. Kline LW & Karpinski E 2008 Testosterone and dihydrotestosterone inhibit gallbladder motility through multiple signalling pathways. Steroids 73 1174-1180.
21. Knowles RG & Moncada S 1994 Nitric oxide synthases in mammals. Biochemical Journal 298 249-258.
22. Koledova VV & Khalil RA 2007 Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Expert Review of Cardiovascular Therapy 5 1-13.
23. Li J & Al-Azzawi F 2009 Mechanism of androgen receptor action. Maturitas 63 142-148.
24. Ling S, Dai A, Williams MR, Myles K, Dilley RJ, Komesaroff PA & Sudhir K 2002 Testosterone enhances apoptosis related damage in human vascular endothelial cells. Endocrinology 143 1119-1125.
25. Liu J, Hughes TE & Sessa WC 1997 The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. Journal of Cell Biology 137 1525-1535.
26. Liu PY, Death AK & Handelsman DJ 2003 Androgens and cardiovascular disease. Endocrine Reviews 24 313-340.
27. Liu D, Iruthayanathan M, Homan L, Wang Y, Yang L, Wang Y & Dillon J 2008 Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal regulated kinase 1/2-mediated mechanisms. Endocrinology 149 889-898.
28. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 195 265-277.
29. Miller VM & Mulvagh SL 2007 Sex steroids and endothelial function: translating basic science to clinical practice. Trends in Pharmacological Sciences 28 263-270.
30. Miller VM & Duckles SP 2008 Vascular actions of estrogens: functional implications. Pharmacological Reviews 60 210-241.
31. Moncada S & Higgs EA 2006 Nitric oxide and the vascular endothelium. Handbook of Experimental Pharmacology 176 213-254.
32. Moreno PR, Sanz J & Fuster V 2009 Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. Journal of the American College of Cardiology 53 2315-2323.
33. Mukherjee TK, Dinh H, Chaudhuri G & Nathan L 2002 Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. PNAS 99 4055-4060.
34. Ouyang P, Michos ED & Karas RH 2006 Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. Journal of the American College of Cardiology 47 1741-1753.
35. Perusquía M & Stallone JN 2010 Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites American Journal of Physiology. Heart and Circulatory Physiology 298 H1301-H1307.
36. Polini N, Rauschemberger MB, Mendiberri J, Selles J & Massheimer V 2007 Effect of genistein and raloxifene on vascular dependent platelet aggregation. Molecular and Cellular Endocrinology 267 55-62.
37. Qiao X, Mcconnell KR & Khalil RA 2008 Sex steroids and vascular responses in hypertension and aging. Gender Medicine 5 S46-S64.
38. Rauschemberger MB, Sellés J & Massheimer V 2008 The direct action of estrone on vascular tissue involves genomic and non-genomic actions. Life Sciences 82 115-123.
39. Rowell KO, Hall J, Pugh PJ, Jones TH, Channer KS & Jones RD 2009 Testosterone acts as an efficacious vasodilator in isolated in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations. Journal of Endocrinological Investigation 32 718-773.
40. Sandoval MJ, Cutini PH, Rauschemberger MB & Massheimer VL 2010 The soyabean isoflavone genistein modulates endothelial cell behaviour. British Journal of Nutrition 104 171-179.
41. Selles J, Polini N, Alvarez C &Massheimer V 2005 Novel action of estrone on vascular tissue: regulation of NOS and COX activity. Steroids 70 251-256.
42. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A & Genazzani AR 2003 Dehydroepiandrosterone modulates endothelilal nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144 3449-3455.
43. Tep-areenan P, Kendall DA & Randall MD 2002 Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. British Journal of Pharmacology 135 735-740.
44. Villalobo A 2006 Nitric oxide and cell proliferation. FEBS Journal 273 2329-2344.
45. Villar I, Hobbs A & Ahluwalia A 2008 Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. Journal of Endocrinology 197 447-462.
46. White RE, Han G, Dimitropoulou C, Zhu S, Miyake K, Fulton D, Dave S & Barman SA 2005 Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle. American Journal of Physiology. Heart and Circulatory Physiology 289 H1468-H1475.
47. Williams MR, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K & Komesaroff PA 2004 Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. Journal of Clinical Endocrinology and Metabolism 89 4708-4715.
48. Yu J, Akishita M, Ogawa S, Son B, Kato S, Ouchi Y & Okabe T 2010 Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/AKT pathway. Endocrinology 151 1822-1828.